Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003176963 | SCV003854327 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-11-27 | criteria provided, single submitter | clinical testing | The p.P454T variant (also known as c.1360C>A), located in coding exon 5 of the BARD1 gene, results from a C to A substitution at nucleotide position 1360. The proline at codon 454 is replaced by threonine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV003459794 | SCV004217264 | uncertain significance | Familial cancer of breast | 2023-05-25 | criteria provided, single submitter | clinical testing |